- ... MC, Dumas F, Demoly P. Accuracy of a pharmacovigilance algorithm in diagnosing drug hypersensitivity reactions. Archives of ... in systematic review Machado D, Gomes E. Are pharmacovigilance algorithms trustful for the diagnosis of drug hypersensitivity? ...
- ... product directly to FDA. As standard practice in pharmacovigilance, many sponsors report events potentially associated with another ... the product development cycle and as part of pharmacovigilance; however, other coding systems are also used. For ...
- ... technologies are being used to perform disease and pharmacovigilance surveillance. Recently, in Cambodia, mobile phone-based, SMS text messages were used to conduct pharmacovigilance on 17 different vaccines. 30 Their intention was ...
- ... is commonly used as part of a postmarketing pharmacovigilance program related to a biologic or pharmaceutical product ... 84. Rosati K. Using electronic health information for pharmacovigilance: the promise and the pitfalls. J Health Life ...
- ... lopinavir/ritonavir: a study using clinical trial and pharmacovigilance databases. Int J Clin Pharmacol Ther. 2012 Jun; ... Sibanda M, Gavi S, et al. Implementing a pharmacovigilance program to evaluate cutaneous adverse drug reactions in ...
- ... the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP), 31 and Methodological Standards for Patient-Centered ... the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) Guide on Methodological Standards in Pharmacoepidemiology. [March ...
- ... 2015;Conference: 15th ISoP Annual Meeting “Cubism in Pharmacovigilance” Prague Czech Republic. Conference Start:. 20151027 Conference End: ...
- ... with donepezil versus memantine: analysis of the French Pharmacovigilance Database. Therapie. 65(3): 255–259. 2010. PMID: ...
- ... leading practices. International collaboration offers several advantages: for pharmacovigilance, a pooled international sample can quicken the discovery ...
- ... review of 17 years' experience in a regional pharmacovigilance center in France. Mov Disord. 2011; 26 :2226– ...
19 results